- Study at RCSI
- Student Life
- Schools & Faculties
- Faculty of Medicine & Health Sciences
- School of Medicine
- School of Pharmacy
- School of Physiotherapy
- School of Postgraduate Studies
- School of Nursing & Midwifery
- Academic Departments
- Institute of Leadership
- Health Professions Education Centre (HPEC)
- Simulation
- Student, Academic & Regulatory Affairs
- Faculty of Sports and Exercise Medicine
- Faculty of Nursing & Midwifery
- Faculty of Dentistry
- Faculty of Radiologists
- Alumni
- Surgical Affairs
- Research & Innovation
- Innovation
- Strategic Academic Recruitment Programme
- Research News & Events
- Research Areas
- Principal Investigators
- Research Networks & Centres
- Technology Cores & Research Facilities
- Research Office
- Employment Opportunities
- PhD Projects and Postgraduate Training Opportunities
- Research Ethics
- Technology Transfer Office & Management of Intellectual Property
- Research by Faculty
- Research by Academic Department
- Research by School
- Human Resources Strategy for Researchers (HRS4R)
- About RCSI
- Council
- CEO and Senior Management
- History
- Annual Report
- Contact us and location
- Communications
- Publications
- Venue hire
- No. 26 York Street
- Athena SWAN
- RCSI and the wider community
- Quality Enhancement Office
- Academic Health Centre
- Irish Society of Urology
- Freedom of Information (FOI)
- Faculty of Medicine & Health Sciences Strategy 2013 - 2017
- Medical Validation Ireland
- Eduroam
- RCSI International
Innovation Quarterly Workshop - Friday 31st March 2017
Speakers:
Dr. Orla Cunningham, Director Biomedicine Design, Pfizer Grange Castle
Prof Jochen Prehn and Prof Leonie Young,
Pfizer collaborators under the SFI-Pfizer Biotherapeutics program
Lunch will be served from 12.45 - Speakers will begin at 1pm.
*** Please RSVP to innovation@rcsi.ie for catering purposes.
- Drug discovery remains a war of attrition and novel approaches are required to accelerate the process & change the paradigm
- The SFI-Pfizer Biotherapeutics Innovation Award Program provides a platform to support engagement between Pfizer and the Irish biomedical community
- The BioMedicine Design group at Grange Castle are uniquely placed to provide a truly collaborative partner for accelerated drug discovery
- RCSI collaborators in the Pfizer biotherapeutics program Jochen Prehn and Leonie Young give their experience of collaborating with industry to develop novel therapeutics
Dr. Orla Cunningham
Following a PhD in Biochemistry at Trinity College Dublin, Orla spent 5 years at the national molecular oncology institute (IFOM) in Milan carrying out postdoctoral research in cancer cell biology. She returned to Ireland in 2006 to establish Wyeth's nascent Protein Discovery & Optimization group in UCD. Her team moved to the Pfizer Grange Castle site post-acquisition in 2009 & continues to support both antibody discovery and optimization programs across Pfizer's diverse therapeutic research units based in the US. The BioMedicine Design group at Grange Castle have been engaged in a unique collaboration with Science Foundation Ireland since 2014, partnering with academic groups across Ireland to accelerate the translation of novel science to biotherapeutic drug development.